Pluristem Therapeutics’ PLX bioreactor system- A cell manufacturing facility with a 3D micro-environment that resembles the setting within the human physique. : Innovation
Pluristem Therapeutics (NASDAQ: PSTI) is an Israeli firm engaged within the improvement of human placental adherent stromal cells for business ...
